Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gallacher

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
British Medical Journal (Clinical Research Ed.)|June 30, 1984
Psychosocial stress in pregnancy and its relation to low birth weightJ Gallacher, A Gallacher
British Dental Journal|October 8, 2016
Dens invaginatus: diagnosis and management strategiesA Gallacher, R Ali, S Bhakta
The Journal of Laboratory and Clinical Medicine|April 1, 1975
Studies on crystal-induced chemotactic factor. II. Role of phagocytosisI Spilberg, A Gallacher, B Mendell
The Journal of Laboratory and Clinical Medicine|April 1, 1977
Calcium pyrophosphate dihydrate (CPPD) crystal-induced chemotactic factor: subcellular localization, role of protein synthesis and phagocytosisI Spilberg, A Gallacher, B Mandell
Agents and Actions|March 1, 1977
A mechanism of action for non-steroidal anti-inflammatory agents in calcium pyrophosphate dihydrate (CPPD) crystal induced arthritisI Spilberg, A Gallacher, B Mandell, et al.
British Dental Journal|March 11, 2017
Bulk-fill resin-based composite restorative materials: a reviewJ Chesterman, A Jowett, A Gallacher, et al.
The Journal of Clinical Investigation|October 1, 1976
Urate crystal-induced chemotactic factor: isolation and partial characterizationI Spilbert, A Gallacher, J M Mehta, et al.
The American Journal of the Medical Sciences|July 1, 1976
Fluorimetric method for the detection of anti-DNA antibodies in serumI Spilberg, A Gallacher, B Mandell, et al.
Journal of Biomedical Materials Research. Part A|October 21, 2003
Local carboplatin delivery and tissue distribution in livers after radiofrequency ablationA Szymanski-Exner, A Gallacher, N T Stowe, et al.
Lupus|December 6, 2012
Safety profile of belimumab: pooled data from placebo-controlled phase 2 and 3 studies in patients with systemic lupus erythematosusD J Wallace, S Navarra, M A Petri, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
British Medical Journal (Clinical Research Ed.)|June 30, 1984
Psychosocial stress in pregnancy and its relation to low birth weightJ Gallacher, A Gallacher
British Dental Journal|October 8, 2016
Dens invaginatus: diagnosis and management strategiesA Gallacher, R Ali, S Bhakta
The Journal of Laboratory and Clinical Medicine|April 1, 1975
Studies on crystal-induced chemotactic factor. II. Role of phagocytosisI Spilberg, A Gallacher, B Mendell
The Journal of Laboratory and Clinical Medicine|April 1, 1977
Calcium pyrophosphate dihydrate (CPPD) crystal-induced chemotactic factor: subcellular localization, role of protein synthesis and phagocytosisI Spilberg, A Gallacher, B Mandell
Agents and Actions|March 1, 1977
A mechanism of action for non-steroidal anti-inflammatory agents in calcium pyrophosphate dihydrate (CPPD) crystal induced arthritisI Spilberg, A Gallacher, B Mandell, et al.
British Dental Journal|March 11, 2017
Bulk-fill resin-based composite restorative materials: a reviewJ Chesterman, A Jowett, A Gallacher, et al.
The Journal of Clinical Investigation|October 1, 1976
Urate crystal-induced chemotactic factor: isolation and partial characterizationI Spilbert, A Gallacher, J M Mehta, et al.
The American Journal of the Medical Sciences|July 1, 1976
Fluorimetric method for the detection of anti-DNA antibodies in serumI Spilberg, A Gallacher, B Mandell, et al.
Journal of Biomedical Materials Research. Part A|October 21, 2003
Local carboplatin delivery and tissue distribution in livers after radiofrequency ablationA Szymanski-Exner, A Gallacher, N T Stowe, et al.
Lupus|December 6, 2012
Safety profile of belimumab: pooled data from placebo-controlled phase 2 and 3 studies in patients with systemic lupus erythematosusD J Wallace, S Navarra, M A Petri, et al.
Pageof 1